Rock Springs Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-255,500
| Closed | -$29.6M | – | 123 |
|
|
2023
Q3 | $29.6M | Sell |
255,500
-239,500
| -48% | -$27.7M | 0.79% | 41 |
|
|
2023
Q2 | $50.9M | Sell |
495,000
-245,100
| -33% | -$25.2M | 1.21% | 28 |
|
|
2023
Q1 | $80.8M | Buy |
740,100
+400
| +0.1% | +$43.7K | 1.93% | 17 |
|
|
2022
Q4 | $84.2M | Buy |
739,700
+12,700
| +2% | +$1.45M | 2.03% | 13 |
|
|
2022
Q3 | $45M | Sell |
727,000
-19,000
| -3% | -$1.18M | 1.16% | 27 |
|
|
2022
Q2 | $59.5M | Hold |
746,000
| – | – | 1.73% | 15 |
|
|
2022
Q1 | $78.5M | Hold |
746,000
| – | – | 1.98% | 11 |
|
|
2021
Q4 | $80.4M | Buy |
746,000
+44,000
| +6% | +$4.74M | 1.86% | 14 |
|
|
2021
Q3 | $76.9M | Buy |
702,000
+77,000
| +12% | +$8.43M | 1.62% | 16 |
|
|
2021
Q2 | $58.5M | Hold |
625,000
| – | – | 1.16% | 26 |
|
|
2021
Q1 | $57.5M | Hold |
625,000
| – | – | 1.26% | 25 |
|
|
2020
Q4 | $45.7M | Sell |
625,000
-25,000
| -4% | -$1.83M | 0.97% | 33 |
|
|
2020
Q3 | $50.5M | Buy |
+650,000
| New | +$50.5M | 1.28% | 23 |
|